A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
ConclusionsThis large national study in nsqNSCLC patients confirms thatEGFR exon 20ins is a rare condition (0.6%). The prognosis associated with exon 20ins appears to be in line with that of wild-typeEGFR, but worse than commonEGFR mutations, highlighting the need for advancements for this rare population.
Source: Targeted Oncology - Category: Cancer & Oncology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Economics | Epidemiology | Immunotherapy | Lung Cancer | Non-Small Cell Lung Cancer | Smokers | Study